… Sorafenib-loaded lactobionic acid conjugated G(4)PAMAM-FITC dendrimers were
investigated by Iacobazzi and co-workers for the targeting of human liver cancer cells. …

… the liver tumor cells, therefore, increase selective targeting of … and lactobionic acid (MSN-CS-LA
nanocarriers) to target … have shown that sorafenib loaded with dendrimer exhibits superi…

… high loading efficiency of DNA and enhances the cellular … to the widely used PAMAM
dendrimer (G4) which needs multi-… LA moieties against human liver carcinoma cell line (HepG2). …

… Patent literature status related to application of dendrimers in liver disorders … Targeting
human liver cancer cells with lactobionic acid-G (4)-PAMAM-FITC sorafenib loaded dendrimers. Int…

… dendrimer encapsulating the anticancer drug sorafenib and … targeting specificity of Ac-La-G(4)-PAMAM-FITC
dendrimer … Targeting human liver cancer cells with lactobionic acid-G(4)-…

… -human serum albumin-sorafenib nanoparticles (FA-HSA-SRF-NPs) to improve the active-targeting
to liver tumor cells … sorafenib-loaded human serum albumin nanoparticles with active-…

… The ideal anticancer nanoformulations for tumor-targeted … exerted to kill the tumor cells and
inhibit the tumor growth. However, … However, cationic PAMAM dendrimers could be rapidly …

… GAPDH was used as a control for the loaded amount of the … dendrimers on HER2-positive
human breast cancer cell lines (… line models, we investigated the downstream target of HER1 …

… drug sorafenib, which is able to target… human liver cancer cells, characterized by undetectable
level of receptor, confirmed the targeting specificity of Ac-La-G(4)-PAMAM-FITC dendrimer …

… Clicking on the donut icon will load a page at altmetric.com … , and (3) lactobionic acid (LBA)
for cancer recognition. The … between engineered NK cells and target liver cancer cells, and …